These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24497296)

  • 1. Epidemiology and clinical pathophysiology of uric acid kidney stones.
    Sakhaee K
    J Nephrol; 2014 Jun; 27(3):241-5. PubMed ID: 24497296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid stone disease: lessons from recent human physiologic studies.
    Tran TVM; Maalouf NM
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):407-413. PubMed ID: 32398609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
    Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.
    Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M
    World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with uric acid stones.
    Heilberg IP
    Urolithiasis; 2016 Feb; 44(1):57-63. PubMed ID: 26645868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric Acid Renal Lithiasis: New Concepts.
    Pazos Pérez F
    Contrib Nephrol; 2018; 192():116-124. PubMed ID: 29393127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and the genesis of uric acid stones.
    Maalouf NM
    J Ren Nutr; 2011 Jan; 21(1):128-31. PubMed ID: 21195936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis.
    Trinchieri A; Croppi E; Simonelli G; Sciorio C; Montanari E
    Urolithiasis; 2020 Apr; 48(2):123-129. PubMed ID: 31037403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?
    Adomako EA; Maalouf NM
    Curr Opin Nephrol Hypertens; 2023 Mar; 32(2):145-152. PubMed ID: 36683539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the pathophysiology and management of uric acid renal stones.
    Kenny JE; Goldfarb DS
    Curr Rheumatol Rep; 2010 Apr; 12(2):125-9. PubMed ID: 20425021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid nephrolithiasis: An update.
    Cicerello E
    Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of renal uric acid stones in the adult.
    Trinchieri A; Montanari E
    Urolithiasis; 2017 Dec; 45(6):553-562. PubMed ID: 28258472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.